BIOMAT Database Logo BIOMAT Database Logo

Increased urinary free immunoglobulin light chain excretion in patients with multiple sclerosis. 2010

Ruth Dobson, and R F Miller, and H E Palmer, and M Feldmann, and E J Thompson, and A J Thompson, and D H Miller, and G Giovannoni
Neuroimmunology Unit, Queen Mary University of London, Blizard Institute of Cell and Molecular Science, Barts and The London School of Medicine and Dentistry, 4 Newark Street, Whitechapel, London E1 2AT, United Kingdom. ruth.dobson@qmul.ac.uk

BACKGROUND Plasma and B cells are implicated in multiple sclerosis (MS) and produce free light chains (FLC) that are excreted in urine. OBJECTIVE To confirm that demyelinating diseases (DD) cause increased urinary FLCs. METHODS Urinary FLC in 50 patients with DD were compared to 20 patients with posterior uveitis (PU), 19 with AIDS, 34 with rheumatoid arthritis (RA) and 19 normal controls (NC). RESULTS Subjects with DD, PU, RA and AIDS have higher urinary FLCs than NC (p<0.01). Urinary FLCs did not correlate with gadolinium-enhancing lesions on MRI. CONCLUSIONS Urinary FLCs are raised in DD. Further studies are required to see if they correlate with disease activity.

UI MeSH Term Description Entries
D007136 Immunoglobulins Multi-subunit proteins which function in IMMUNITY. They are produced by B LYMPHOCYTES from the IMMUNOGLOBULIN GENES. They are comprised of two heavy (IMMUNOGLOBULIN HEAVY CHAINS) and two light chains (IMMUNOGLOBULIN LIGHT CHAINS) with additional ancillary polypeptide chains depending on their isoforms. The variety of isoforms include monomeric or polymeric forms, and transmembrane forms (B-CELL ANTIGEN RECEPTORS) or secreted forms (ANTIBODIES). They are divided by the amino acid sequence of their heavy chains into five classes (IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M) and various subclasses. Globulins, Immune,Immune Globulin,Immune Globulins,Immunoglobulin,Globulin, Immune
D007147 Immunoglobulin Light Chains Polypeptide chains, consisting of 211 to 217 amino acid residues and having a molecular weight of approximately 22 kDa. There are two major types of light chains, kappa and lambda. Two Ig light chains and two Ig heavy chains (IMMUNOGLOBULIN HEAVY CHAINS) make one immunoglobulin molecule. Ig Light Chains,Immunoglobulins, Light-Chain,Immunoglobulin Light Chain,Immunoglobulin Light-Chain,Light-Chain Immunoglobulins,Chains, Ig Light,Chains, Immunoglobulin Light,Immunoglobulins, Light Chain,Light Chain Immunoglobulins,Light Chain, Immunoglobulin,Light Chains, Ig,Light Chains, Immunoglobulin,Light-Chain, Immunoglobulin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Ruth Dobson, and R F Miller, and H E Palmer, and M Feldmann, and E J Thompson, and A J Thompson, and D H Miller, and G Giovannoni
[Urinary excretion of free amino acids in patients with multiple sclerosis].
January 1989, Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952),
Ruth Dobson, and R F Miller, and H E Palmer, and M Feldmann, and E J Thompson, and A J Thompson, and D H Miller, and G Giovannoni
Free immunoglobulin light-chain serum levels in the follow-up of patients with monoclonal gammopathies: correlation with 24-hr urinary light-chain excretion.
April 2004, American journal of hematology,
Ruth Dobson, and R F Miller, and H E Palmer, and M Feldmann, and E J Thompson, and A J Thompson, and D H Miller, and G Giovannoni
Urinary free kappa light chain levels in chronic progressive multiple sclerosis.
January 1994, Pathobiology : journal of immunopathology, molecular and cellular biology,
Ruth Dobson, and R F Miller, and H E Palmer, and M Feldmann, and E J Thompson, and A J Thompson, and D H Miller, and G Giovannoni
Highly related immunoglobulin light chain sequences in different multiple sclerosis patients.
December 1999, Journal of neuroimmunology,
Ruth Dobson, and R F Miller, and H E Palmer, and M Feldmann, and E J Thompson, and A J Thompson, and D H Miller, and G Giovannoni
Increased free light chains in the urine from patients with multiple sclerosis.
April 1991, Neurology,
Ruth Dobson, and R F Miller, and H E Palmer, and M Feldmann, and E J Thompson, and A J Thompson, and D H Miller, and G Giovannoni
Multiple sclerosis: assay of free immunoglobulin light chains.
January 2017, Annals of clinical biochemistry,
Ruth Dobson, and R F Miller, and H E Palmer, and M Feldmann, and E J Thompson, and A J Thompson, and D H Miller, and G Giovannoni
[Free light-chain immunoglobulins in the biological fluids of patients with multiple sclerosis].
January 1997, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova,
Ruth Dobson, and R F Miller, and H E Palmer, and M Feldmann, and E J Thompson, and A J Thompson, and D H Miller, and G Giovannoni
Primary cerebral immunoglobulin light chain amyloidoma in a patient with multiple sclerosis.
January 2024, BMJ case reports,
Ruth Dobson, and R F Miller, and H E Palmer, and M Feldmann, and E J Thompson, and A J Thompson, and D H Miller, and G Giovannoni
Correlation of serum immunoglobulin free light chain quantification with urinary Bence Jones protein in light chain myeloma.
January 2002, Clinical chemistry,
Ruth Dobson, and R F Miller, and H E Palmer, and M Feldmann, and E J Thompson, and A J Thompson, and D H Miller, and G Giovannoni
[Urinary excretion of hydroxyproline by patients with multiple sclerosis].
January 1988, Neurologia i neurochirurgia polska,
Copied contents to your clipboard!